References

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

10.1002/1529-0131(199907)42:7<1309::aid-anr1>3.0.co;2-f · 1999 · External reference

Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera

10.1093/humrep/12.9.2061 · 1997 · External reference

Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome

10.1093/humrep/14.2.489 · 1999 · External reference

Effect of anticardiolipin antibodies on prolactin and insulin-like growth factor binding protein-1 production by human decidual cells

10.1111/j.1600-0897.1999.tb00534.x · 1999 · External reference

Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR

10.1095/biolreprod53.4.905 · 1995 · External reference

Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion

10.1095/biolreprod56.1.50 · 1997 · External reference

Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology

10.1016/0165-0378(92)90003-m · 1992 · External reference

Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions

1994 · External reference

Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)

10.1093/humrep/14.8.1956 · 1999 · External reference

Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome

10.1016/s0002-9378(99)70507-7 · 1999 · External reference

Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome

10.1016/s0029-7844(97)00065-3 · 1997 · External reference

Anti-phospholipid antibodies and Beta2-glycoprotein-I in 500 women with recurrent miscarriage: Results of a comprehensive screening approach

10.1093/oxfordjournals.humrep.a136224 · 1995 · External reference

Anticardiolipin antibodies: clinical consequences of ‘low titers’

10.1016/0029-7844(95)00497-1 · 1996 · External reference

Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test

10.1001/archinte.1986.00360230069012 · 1986 · External reference

Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study

10.7326/0003-4819-120-6-199403150-00004 · 1994 · External reference

A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies

10.1016/s0002-9378(11)91619-6 · 1992 · External reference

Variable effects on murine pregnancy of immunoglobulin G fractions from women with antiphospholipid antibodies

10.1016/s0002-9378(97)70466-6 · 1997 · External reference

Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients

10.1016/0002-9378(93)90410-k · 1993 · External reference

Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss

10.1056/nejm199707173370302 · 1997 · External reference

Antiphospholipid antibody-associated recurrent prengancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

10.1016/s0002-9378(96)70610-5 · 1996 · External reference

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

10.1136/bmj.314.7076.253 · 1997 · External reference

Unresolved reference

1989 · External reference

Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study

10.1093/humrep/14.11.2876 · 1999 · External reference

Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin

10.1111/j.1471-0528.1999.tb08208.x · 1999 · External reference

Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled study

10.1016/s0015-0282(99)00088-6 · 1999 · External reference

A matched study to determine whether low-dose aspirin without heparin improves pregnancy rates following frozen embryo transfer and/or affects endometrial sonographic parameters

10.1023/a:1020373009043 · 1998 · External reference

Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin

10.1093/humrep/12.6.1171 · 1997 · External reference

Effect of intrauterine administration of antiprostaglandin drugs on implantation in the rat

10.1016/0010-7824(81)90041-x · 1981 · External reference

Inhibitory effects of indomethacin on implantation and its related phenomena

10.1177/030006059602400407 · 1996 · External reference

Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery

10.1136/bmj.315.7104.372 · 1997 · External reference

Thrombosis in pregnancy: maternal and fetal issues

10.1016/s0140-6736(98)10265-9 · 1999 · External reference

A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin

10.1111/j.1600-0897.1996.tb00501.x · 1996 · External reference

Marked variation in antiphospholipid antibodies during pregnancy: relationships to pregnancy outcome

10.1093/humrep/14.1.224 · 1999 · External reference

Future pregnancy outcome in unexplained recurrent first trimester miscarriage

10.1093/humrep/12.2.387 · 1997 · External reference

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

10.1016/s0002-9378(16)32527-3 · 1982 · External reference

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

10.1016/0028-2243(91)90021-c · 1991 · External reference

Aspirin modulates interleukin-3 production: additional explanation for the preventive effects of aspirin in antiphospholipid antibody syndrome

1995 · External reference

Interaction of heparin with antiphospholipid antibodies (APA) from the sera of women with recurrent pregnancy loss (RPL)

10.1111/j.1600-0897.1995.tb01133.x · 1995 · External reference

Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study

10.1093/humrep/14.11.2727 · 1999 · External reference

Pre-implantation endometrial leukocytes in women with recurrent miscarriage

10.1093/humrep/14.9.2386 · 1999 · External reference

Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage

10.1093/humupd/5.5.475 · 1999 · External reference

A multicenter placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group

10.1016/s0002-9378(00)70500-x · 2000 · External reference